[{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D287H","proteinChange":"D287H","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816E","proteinChange":"D816E","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600D","proteinChange":"V600D","cancerType":"Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Colorectal Cancer","level":"3A","drugs":"Panitumumab + Dabrafenib + Trametinib","pmids":"19884556, 29431699, 20619739, 19001320, 22448344","abstracts":""},{"isoform":"ENST00000355710","refSeq":"NM_020975.4","entrezGeneId":5979,"gene":"RET","variant":"Fusions","proteinChange":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Cabozantinib","pmids":"28447912, 27825636, 23533264","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469R","proteinChange":"G469R","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Melanoma","level":"3A","drugs":"Binimetinib, Binimetinib + Ribociclib","pmids":"16273091, 28284557, 22983396","abstracts":"Schuler et al. Abstract #9519, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.9519"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600G","proteinChange":"V600G","cancerType":"Colorectal Cancer","level":"3A","drugs":"Panitumumab + Dabrafenib + Trametinib","pmids":"19884556, 29431699, 20619739, 19001320, 22448344","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 insertion","proteinChange":"729_761ins","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"28336552, 22190593","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Sorafenib","pmids":"23140824, 22270258","abstracts":"Kindler et al. Abstract# 10009, ASCO 2011 http://meetinglibrary.asco.org/content/80567-102"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"27283860, 28919011","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"N581S","proteinChange":"N581S","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000241453","refSeq":"NM_004119.2","entrezGeneId":2322,"gene":"FLT3","variant":"FLT3 internal tandem duplications","proteinChange":"Y572_Y630ins","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Sorafenib","pmids":"18230792, 22368270","abstracts":""},{"isoform":"ENST00000219476","refSeq":"NM_000548.3","entrezGeneId":7249,"gene":"TSC2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"CNS Cancer","level":"1","drugs":"Everolimus","pmids":"23158522","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"Temsirolimus, Everolimus","pmids":"24631838, 27482884, 26831717, 24622468","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T263P","proteinChange":"T263P","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R140Q","proteinChange":"R140Q","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"28588020","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Amplification","proteinChange":"Amplification","cancerType":"Esophagogastric Cancer","level":"1","drugs":"Trastuzumab","pmids":"20728210","abstracts":""},{"isoform":"ENST00000380152","refSeq":"NM_000059.3","entrezGeneId":675,"gene":"BRCA2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"2A","drugs":"Olaparib","pmids":"25366685, 24882434","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816A","proteinChange":"D816A","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000206249","refSeq":"NM_001122740.1","entrezGeneId":2099,"gene":"ESR1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"AZD9496, Fulvestrant","pmids":"27986707, 27269946","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Fusions","proteinChange":"Fusions","cancerType":"Myelodysplasia","level":"1","drugs":"Imatinib","pmids":"12944919, 17555450, 12660384, 16498388, 14504092, 16845659, 18950453, 15034867","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"E2419K","proteinChange":"E2419K","cancerType":"Bladder Cancer","level":"3A","drugs":"Everolimus","pmids":"24625776, 23551593","abstracts":""},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Wildtype","proteinChange":"Wildtype","cancerType":"Colorectal Cancer","level":"1","drugs":"Regorafenib, Panitumumab, Cetuximab","pmids":"20921462, 24739896, 20921465, 19339720, 15677699, 23177514","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"Fusions","proteinChange":"Fusions","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"29848605, 26324363, 22837387","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597V","proteinChange":"L597V","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816E","proteinChange":"D816E","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1009_splice","proteinChange":"X1009_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816F","proteinChange":"D816F","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"S768I","proteinChange":"S768I","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"17285735, 28336552, 25521405, 26051236","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"963_D1010splice","proteinChange":"963_D1010splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650T","proteinChange":"K650T","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L858R","proteinChange":"L858R","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Osimertinib, Gefitinib","pmids":"22452895, 25589191, 23816960, 22285168, 20022809, 19692680, 27987585, 21670455, 29151359, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"E709K","proteinChange":"E709K","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"28336552, 23566546, 18000506, 25179728, 25130612, 23749122, 15710947","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469V","proteinChange":"G469V","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000357654","refSeq":"NM_007294.3","entrezGeneId":672,"gene":"BRCA1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"2A","drugs":"Olaparib","pmids":"25366685, 24882434","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132H","proteinChange":"R132H","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169, 29860938","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Amplification","proteinChange":"Amplification","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L747P","proteinChange":"L747P","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28336552, 22190593","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Amplification","proteinChange":"Amplification","cancerType":"Breast Cancer","level":"1","drugs":"Lapatinib + Trastuzumab, Pertuzumab + Trastuzumab, Ado-Trastuzumab Emtansine, Lapatinib, Neratinib, Trastuzumab","pmids":"22149875, 16236738, 19060928, 19786658, 22153890, 26874901, 29320312, 22257673, 23020162, 29146401, 16091755, 23602601, 17192538","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"D842V","proteinChange":"D842V","cancerType":"Gastrointestinal Stromal Tumor","level":"R1","drugs":"Imatinib","pmids":"25905001, 17087936, 12949711, 24963404, 22718859, 15928335, 18955458, 23752188, 22745105, 15685537, 18794084","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719A","proteinChange":"G719A","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 15118073, 26051236, 21670455, 16011858, 24285021, 20573926","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"981_1028splice","proteinChange":"981_1028splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000311189","refSeq":"NM_001130442.1","entrezGeneId":3265,"gene":"HRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Head and Neck Squamous Cell Carcinoma","level":"3A","drugs":"Tipifarnib","pmids":"12497061, 24240680","abstracts":"Ho et al. Abstract# TPS2618, JCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.TPS2618"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816V","proteinChange":"D816V","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L861R","proteinChange":"L861R","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 26051236","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Vemurafenib + Cobimetinib, Dabrafenib + Trametinib, Trametinib, Encorafenib + Binimetinib","pmids":"29573941, 22735384, 28961848, 25265494, 25287827, 25399551, 22608338, 23051966, 28891408, 27480103, 22663011, 25265492, 24508103, 29361468, 28991513, 23020132","abstracts":""},{"isoform":"ENST00000377045","refSeq":"NM_001654.4","entrezGeneId":369,"gene":"ARAF","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Sorafenib","pmids":"24569458","abstracts":""},{"isoform":"ENST00000263121","refSeq":"NM_003073.3","entrezGeneId":6598,"gene":"SMARCB1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"Tazemetostat","pmids":"23620515, 20951942, 27391784","abstracts":"Chi et al. Abstract# A175, AACR-NCI-EORTC 2017 http://www.abstractsonline.com/pp8/#!/4557/presentation/616"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1007_splice","proteinChange":"X1007_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"G1202R","proteinChange":"G1202R","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Lorlatinib","pmids":"29074098, 29373100","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Imatinib","pmids":"22718859","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"G370C","proteinChange":"G370C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","proteinChange":"V600K","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib + Cobimetinib, Dabrafenib + Trametinib, Trametinib, Encorafenib + Binimetinib","pmids":"29573941, 28891408, 27480103, 22663011, 25265492, 25265494, 25287827, 29361468, 28991513, 25399551, 23020132","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003F","proteinChange":"Y1003F","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Thyroid Cancer","level":"3A","drugs":"Selumetinib + Radioiodine Uptake Therapy","pmids":"22105174, 23406027","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010H","proteinChange":"D1010H","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L861Q","proteinChange":"L861Q","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 26051236","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"Q2223K","proteinChange":"Q2223K","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Everolimus","pmids":"24622468","abstracts":""},{"isoform":"ENST00000278616","refSeq":"NM_000051.3","entrezGeneId":472,"gene":"ATM","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Prostate Cancer","level":"4","drugs":"Olaparib","pmids":"26510020","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"Fusions","proteinChange":"Fusions","cancerType":"Ovarian Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"23890088, 26324360, 24345920","abstracts":""},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172K","proteinChange":"R172K","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"28588020","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816N","proteinChange":"D816N","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816Y","proteinChange":"D816Y","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816G","proteinChange":"D816G","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000257904","refSeq":"NM_000075.3","entrezGeneId":1019,"gene":"CDK4","variant":"Amplification","proteinChange":"Amplification","cancerType":"Dedifferentiated Liposarcoma","level":"2A","drugs":"Abemaciclib, Palbociclib","pmids":"23569312, 27124835","abstracts":""},{"isoform":"ENST00000524377","refSeq":"NM_002529.3","entrezGeneId":4914,"gene":"NTRK1","variant":"Fusions","proteinChange":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 28183697","abstracts":"Hyman et al. Abstract# LBA2501, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.18_suppl.LBA2501; Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":"ENST00000381652","refSeq":"NM_004972.3","entrezGeneId":3717,"gene":"JAK2","variant":"PCM1-JAK2 Fusion","proteinChange":"PCM1-JAK2 Fusion","cancerType":"Leukemia","level":"3A","drugs":"Ruxolitinib","pmids":"22899477, 25207766, 26202607, 23630205, 22875628, 25515960, 23400675, 25260694","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"E709_T710delinsD","proteinChange":"E709_T710delinsD","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"21531810, 28336552, 26206867","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T790M","proteinChange":"T790M","cancerType":"Non-Small Cell Lung Cancer","level":"R1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"24478319, 26051236, 23816963","abstracts":"Yang et al. Abstract# O03.05, IASLC 2013 http://library.iaslc.org/search-speaker?search_speaker=17991"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816F","proteinChange":"D816F","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000331920","refSeq":"NM_000264.3","entrezGeneId":5727,"gene":"PTCH1","variant":"Truncating Mutations","proteinChange":"Truncating Mutations","cancerType":"Embryonal Tumor","level":"3A","drugs":"Sonidegib","pmids":"24900187, 24523439","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600R","proteinChange":"V600R","cancerType":"Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600D","proteinChange":"V600D","cancerType":"Colorectal Cancer","level":"3A","drugs":"Panitumumab + Dabrafenib + Trametinib","pmids":"19884556, 29431699, 20619739, 19001320, 22448344","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","proteinChange":"V654A","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"Neratinib","pmids":"23220880","abstracts":"Hyman et al. Abstract# CT001, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/CT001"},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"26438159, 25169980, 27870574, 23082000","abstracts":"Brichory F et al. Abstract# 2088, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/2088"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","proteinChange":"V600K","cancerType":"Colorectal Cancer","level":"3A","drugs":"Panitumumab + Dabrafenib + Trametinib","pmids":"19884556, 29431699, 20619739, 19001320, 22448344","abstracts":""},{"isoform":"ENST00000371953","refSeq":"NM_000314.4","entrezGeneId":5728,"gene":"PTEN","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"GSK2636771, AZD8186","pmids":"28645941","abstracts":"Hansen et al. Abstract# 2570, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2570"},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 deletion/insertion","proteinChange":"729_761indel","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Osimertinib, Gefitinib","pmids":"22452895, 25589191, 23816960, 22285168, 20022809, 19692680, 27987585, 21670455, 29151359, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"Fusions","proteinChange":"Fusions","cancerType":"Inflammatory Myofibroblastic Tumor","level":"2A","drugs":"Crizotinib, Ceritinib","pmids":"26020125, 24670165, 20979472, 23598171","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 20 insertion","proteinChange":"762_823ins","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Poziotinib","pmids":"27188206, 29686424","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","proteinChange":"V654A","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816H","proteinChange":"D816H","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650E","proteinChange":"K650E","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1006_splice","proteinChange":"X1006_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","proteinChange":"T670I","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 19461405, 25592632, 20571495","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597R","proteinChange":"L597R","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000391945","refSeq":"NM_000400.3","entrezGeneId":2068,"gene":"ERCC2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Bladder Cancer","level":"3A","drugs":"Cisplatin","pmids":"12208738, 25096233, 27310333","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003N","proteinChange":"Y1003N","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"L1460P","proteinChange":"L1460P","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Temsirolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1009_splice","proteinChange":"X1009_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Imatinib, Sunitinib","pmids":"28196207, 18955451, 18235122, 12181401, 17046465, 23177515","abstracts":""},{"isoform":"ENST00000318560","refSeq":"NM_005157.4","entrezGeneId":25,"gene":"ABL1","variant":"BCR-ABL1 Fusion","proteinChange":"BCR-ABL1 Fusion","cancerType":"Acute Lymphoid Leukemia","level":"1","drugs":"Dasatinib, Imatinib","pmids":"17496201, 11287973, 24441288, 20131302, 21931113, 12200353","abstracts":""},{"isoform":"ENST00000380152","refSeq":"NM_000059.3","entrezGeneId":675,"gene":"BRCA2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"1","drugs":"Rucaparib, Niraparib","pmids":"27717299, 28882436, 28916367","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132C","proteinChange":"R132C","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169, 29860938","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816V","proteinChange":"D816V","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T790M","proteinChange":"T790M","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Osimertinib","pmids":"25923549, 27751847, 29151359","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594H","proteinChange":"D594H","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Histiocytic Disorder","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816A","proteinChange":"D816A","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","proteinChange":"Fusions","cancerType":"Myelodysplasia","level":"1","drugs":"Imatinib","pmids":"16960151, 12676775, 12181402, 14504092, 18950453, 24687085, 22897847, 26355392, 1516603","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A289V","proteinChange":"A289V","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816Y","proteinChange":"D816Y","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719C","proteinChange":"G719C","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 15118073, 26051236, 21670455, 16011858, 24285021, 20573926","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000318560","refSeq":"NM_005157.4","entrezGeneId":25,"gene":"ABL1","variant":"BCR-ABL1 Fusion","proteinChange":"BCR-ABL1 Fusion","cancerType":"Chronic Myelogenous Leukemia","level":"1","drugs":"Nilotinib, Dasatinib, Imatinib","pmids":"28095277, 28218239, 27217448, 11287973, 12637609, 20525993, 20525995, 11287972, 23502220","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1007_splice","proteinChange":"X1007_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","proteinChange":"T670I","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Sunitinib","pmids":"17046465, 17699867, 23177515","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","proteinChange":"V654A","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Sunitinib","pmids":"17046465, 23177515","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719S","proteinChange":"G719S","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 15118073, 26051236, 21670455, 16011858, 24285021, 20573926","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132S","proteinChange":"R132S","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169, 29860938","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816N","proteinChange":"D816N","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G596D","proteinChange":"G596D","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 deletion","proteinChange":"729_761del","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Osimertinib, Gefitinib","pmids":"22452895, 25589191, 23816960, 22285168, 20022809, 19692680, 27987585, 21670455, 29151359, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003F","proteinChange":"Y1003F","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816H","proteinChange":"D816H","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"K601T","proteinChange":"K601T","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000368508","refSeq":"NM_002944.2","entrezGeneId":6098,"gene":"ROS1","variant":"Fusions","proteinChange":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Crizotinib","pmids":"25264305, 29596029","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A763_Y764insFQEA","proteinChange":"A763_Y764insFQEA","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"23371856, 24353160, 23969006","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A750P","proteinChange":"A750P","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28336552, 19625781, 25179728, 15737014","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"K601N","proteinChange":"K601N","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Amplification","proteinChange":"Amplification","cancerType":"Renal Cell Carcinoma","level":"2A","drugs":"Cabozantinib","pmids":"27279544, 27462141","abstracts":""},{"isoform":null,"refSeq":null,"entrezGeneId":-2,"gene":"Other Biomarkers","variant":"Microsatellite Instability-High","proteinChange":"MSI-H","cancerType":"All Solid Tumors","level":"1","drugs":"Pembrolizumab","pmids":"28596308, 26028255","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 20 insertion","proteinChange":"762_823ins","cancerType":"Non-Small Cell Lung Cancer","level":"R1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"23371856, 24065731, 19536777, 24353160, 21764376, 18676761, 24893891, 23328547, 1867676, 15897572, 17686547","abstracts":""},{"isoform":"ENST00000298552","refSeq":"NM_000368.4","entrezGeneId":7248,"gene":"TSC1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Renal Cell Carcinoma","level":"2A","drugs":"Everolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000425967","refSeq":"NM_001174067.1","entrezGeneId":2260,"gene":"FGFR1","variant":"Amplification","proteinChange":"Amplification","cancerType":"Lung Squamous Cell Carcinoma","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"27870574, 23082000","abstracts":"Voss, MH et al. Abstract# 2500, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2500"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","proteinChange":"T670I","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600R","proteinChange":"V600R","cancerType":"Colorectal Cancer","level":"3A","drugs":"Panitumumab + Dabrafenib + Trametinib","pmids":"19884556, 29431699, 20619739, 19001320, 22448344","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Amplification","proteinChange":"Amplification","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","proteinChange":"Fusions","cancerType":"Myeloproliferative Neoplasm","level":"1","drugs":"Imatinib","pmids":"16960151, 12676775, 12181402, 14504092, 18950453, 24687085, 22897847, 26355392, 1516603","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"E2014K","proteinChange":"E2014K","cancerType":"Bladder Cancer","level":"3A","drugs":"Everolimus","pmids":"24625776, 23551593","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"981_1028splice","proteinChange":"981_1028splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000377045","refSeq":"NM_001654.4","entrezGeneId":369,"gene":"ARAF","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Histiocytosis","level":"3A","drugs":"Sorafenib","pmids":"24569458, 26566875","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Anaplastic Thyroid Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"29072975","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816V","proteinChange":"D816V","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","proteinChange":"E17K","cancerType":"Breast Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000277120","refSeq":"NM_006180.3","entrezGeneId":4915,"gene":"NTRK2","variant":"Fusions","proteinChange":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 28183697","abstracts":"Hyman et al. Abstract# LBA2501, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.18_suppl.LBA2501; Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":"ENST00000462284","refSeq":"NM_002392.5","entrezGeneId":4193,"gene":"MDM2","variant":"Amplification","proteinChange":"Amplification","cancerType":"Liposarcoma","level":"3A","drugs":"DS-3032b, RG7112","pmids":"23400593, 23084521","abstracts":"Gounder et al. Abstract# 2581, ASCO 2016 http://meetinglibrary.asco.org/content/166204-176"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"S371C","proteinChange":"S371C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003N","proteinChange":"Y1003N","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003C","proteinChange":"Y1003C","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X963_splice","proteinChange":"X963_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594A","proteinChange":"D594A","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816G","proteinChange":"D816G","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","proteinChange":"E17K","cancerType":"Endometrial Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"Fusions","proteinChange":"Fusions","cancerType":"Melanoma","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"26314551, 23890088, 24345920, 26072686","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466V","proteinChange":"G466V","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594G","proteinChange":"D594G","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"963_D1010splice","proteinChange":"963_D1010splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L833V","proteinChange":"L833V","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21949883, 23912954, 25130612, 20808254, 21422421","abstracts":""},{"isoform":"ENST00000358273","refSeq":"NM_001042492.2","entrezGeneId":4763,"gene":"NF1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"Cobimetinib, Trametinib","pmids":"24576830, 26936308, 24535670","abstracts":""},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Fusions","proteinChange":"Fusions","cancerType":"Cholangiocarcinoma","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"29182496, 24122810","abstracts":"Cleary et al. Abstract# 447, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155948/abstract"},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172G","proteinChange":"R172G","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"28588020","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"R108K","proteinChange":"R108K","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650M","proteinChange":"K650M","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib","pmids":"23177515","abstracts":""},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Colorectal Cancer","level":"R1","drugs":"Panitumumab, Cetuximab","pmids":"21228335, 20619739, 18316791, 20921465, 24024839","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"S249C","proteinChange":"S249C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172M","proteinChange":"R172M","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"28588020","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132Q","proteinChange":"R132Q","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169, 29860938","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000331920","refSeq":"NM_000264.3","entrezGeneId":5727,"gene":"PTCH1","variant":"Truncating Mutations","proteinChange":"Truncating Mutations","cancerType":"Skin Cancer, Non-Melanoma","level":"3A","drugs":"Sonidegib, Vismodegib","pmids":"29320312, 24900187, 22670903, 22670904, 24523439","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"Fusions","proteinChange":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Crizotinib, Brigatinib, Alectinib, Ceritinib","pmids":"28586279, 29596029, 29668860, 28475456, 28126333, 23724913","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469E","proteinChange":"G469E","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"G380R","proteinChange":"G380R","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G464E","proteinChange":"G464E","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V459L","proteinChange":"V459L","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"M277E","proteinChange":"M277E","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28979142","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816F","proteinChange":"D816F","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010H","proteinChange":"D1010H","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650N","proteinChange":"K650N","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"R248C","proteinChange":"R248C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000304494","refSeq":"NM_000077.4","entrezGeneId":1029,"gene":"CDKN2A","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"Abemaciclib, Palbociclib, Ribociclib","pmids":"19874578, 25941111, 24495407, 29232554, 28283584","abstracts":""},{"isoform":"ENST00000357654","refSeq":"NM_007294.3","entrezGeneId":672,"gene":"BRCA1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"1","drugs":"Rucaparib, Niraparib","pmids":"27717299, 28882436, 28916367","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010N","proteinChange":"D1010N","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Kinase Domain Duplication","proteinChange":"KDD","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28336552, 26286086","abstracts":""},{"isoform":"ENST00000298552","refSeq":"NM_000368.4","entrezGeneId":7248,"gene":"TSC1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"CNS Cancer","level":"1","drugs":"Everolimus","pmids":"23158522","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816G","proteinChange":"D816G","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"L2427Q","proteinChange":"L2427Q","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Temsirolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"F595L","proteinChange":"F595L","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003C","proteinChange":"Y1003C","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Fusions","proteinChange":"Fusions","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"26324363, 27870574, 24122810","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Neratinib","pmids":"23220880","abstracts":"Hyman et al. Abstract# CT001, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/CT001"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"S467L","proteinChange":"S467L","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650R","proteinChange":"K650R","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","proteinChange":"V600K","cancerType":"Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1008_splice","proteinChange":"X1008_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Fusions","proteinChange":"Fusions","cancerType":"Myeloproliferative Neoplasm","level":"1","drugs":"Imatinib","pmids":"12944919, 17555450, 12660384, 16498388, 14504092, 16845659, 18950453, 15034867","abstracts":""},{"isoform":"ENST00000257904","refSeq":"NM_000075.3","entrezGeneId":1019,"gene":"CDK4","variant":"Amplification","proteinChange":"Amplification","cancerType":"Well-Differentiated Liposarcoma","level":"2A","drugs":"Abemaciclib, Palbociclib","pmids":"23569312, 27124835","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"Y373C","proteinChange":"Y373C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010Y","proteinChange":"D1010Y","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650Q","proteinChange":"K650Q","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"L2209V","proteinChange":"L2209V","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Temsirolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G596R","proteinChange":"G596R","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","proteinChange":"E17K","cancerType":"Ovarian Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816Y","proteinChange":"D816Y","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000425967","refSeq":"NM_001174067.1","entrezGeneId":2260,"gene":"FGFR1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"26438159, 25169980, 27870574, 23082000","abstracts":"Brichory F et al. Abstract# 2088, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/2088"},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"FIP1L1-PDGFRA Fusion","proteinChange":"FIP1L1-PDGFRA Fusion","cancerType":"Leukemia","level":"1","drugs":"Imatinib","pmids":"18950453","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132G","proteinChange":"R132G","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169, 29860938","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466E","proteinChange":"G466E","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816A","proteinChange":"D816A","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000263967","refSeq":"NM_006218.2","entrezGeneId":5290,"gene":"PIK3CA","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"Buparlisib, Serabelisib, Alpelisib + Fulvestrant, Copanlisib, GDC-0077, Taselisib + Fulvestrant, Alpelisib, Buparlisib + Fulvestrant, Taselisib","pmids":"25877889, 29401002, 28490463, 22049316, 24652201, 24608574, 23662903, 22188813, 27672108, 25172762","abstracts":"Di Leo et al. Abstract# S4-07, SABCS 2016 http://cancerres.aacrjournals.org/content/77/4_Supplement/S4-07; Dickler et al. Abstract# 520, ASCO 2016 http://meetinglibrary.asco.org/content/165518-176; Wade et al. Abstract# 9054, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.9054; Juric et al. Abstract# 334, MBCC 2016 http://www.onclive.com/conference-coverage/mbcc-2016/alpelisib-combo-promising-in-pik3ca-altered-heavily-pretreated-breast-cancer; Edgar et al. Abstract# 156, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/156"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010Y","proteinChange":"D1010Y","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172S","proteinChange":"R172S","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"28588020","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466A","proteinChange":"G466A","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Low-Grade Serous Ovarian Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600G","proteinChange":"V600G","cancerType":"Non-Langerhans Cell Histiocytosis/Erdheim-Chester Disease","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1008_splice","proteinChange":"X1008_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000355710","refSeq":"NM_020975.4","entrezGeneId":5979,"gene":"RET","variant":"Fusions","proteinChange":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Vandetanib","pmids":"23578175, 25366691, 27803005, 23584301, 23991695, 23154560, 27825616","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597Q","proteinChange":"L597Q","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816H","proteinChange":"D816H","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Colorectal Cancer","level":"R1","drugs":"Panitumumab, Cetuximab","pmids":"20619739, 24024844, 25110411, 24024839","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816N","proteinChange":"D816N","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010N","proteinChange":"D1010N","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X963_splice","proteinChange":"X963_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1006_splice","proteinChange":"X1006_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"D842V","proteinChange":"D842V","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Dasatinib","pmids":"","abstracts":"Trent et al. Abstract# 10006, ASCO 2011 http://meetinglibrary.asco.org/content/79120-102"},{"isoform":"ENST00000360948","refSeq":"NM_001012338.2","entrezGeneId":4916,"gene":"NTRK3","variant":"Fusions","proteinChange":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 28183697","abstracts":"Hyman et al. Abstract# LBA2501, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.18_suppl.LBA2501; Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":null,"refSeq":null,"entrezGeneId":-2,"gene":"Other Biomarkers","variant":"Microsatellite Instability-High","proteinChange":"MSI-H","cancerType":"Colorectal Cancer","level":"1","drugs":"Nivolumab","pmids":"28734759","abstracts":"Andre et al. Abstract# 553, GCS 2018 https://meetinglibrary.asco.org/record/155742/abstract"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469A","proteinChange":"G469A","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"K601E","proteinChange":"K601E","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 28344857, 24933606, 23248257","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597Q","proteinChange":"L597Q","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597V","proteinChange":"L597V","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597S","proteinChange":"L597S","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Melanoma","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594N","proteinChange":"D594N","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816E","proteinChange":"D816E","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","proteinChange":"Fusions","cancerType":"Dermatofibrosarcoma Protuberans","level":"1","drugs":"Imatinib","pmids":"20439456, 21128251, 15503291, 15746584, 18451237, 15681532, 19620561","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"N581I","proteinChange":"N581I","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G464V","proteinChange":"G464V","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000397938","refSeq":"NM_005243.3","entrezGeneId":2130,"gene":"EWSR1","variant":"EWSR1-FLI1 Fusion","proteinChange":"EWSR1-FLI1 Fusion","cancerType":"Ewing Sarcoma","level":"4","drugs":"TK216","pmids":"19584866","abstracts":"Selvanathan et al. Abstract# 694, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/694"},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"ERK Inhibitors, MEK Inhibitors","pmids":"29247021, 28783719","abstracts":"Bhagwat et al. Abstract# 4973, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/4973"}]